122 related articles for article (PubMed ID: 26698404)
21. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.
Goda AE; Yoshida T; Horinaka M; Yasuda T; Shiraishi T; Wakada M; Sakai T
Oncogene; 2008 May; 27(24):3435-45. PubMed ID: 18193086
[TBL] [Abstract][Full Text] [Related]
22. 4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L.
Anding AL; Jones JD; Newton MA; Curley RW; Clagett-Dame M
Anticancer Res; 2018 Aug; 38(8):4403-4416. PubMed ID: 30061204
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial Ca2+ removal amplifies TRAIL cytotoxicity toward apoptosis-resistant tumor cells via promotion of multiple cell death modalities.
Takata N; Ohshima Y; Suzuki-Karasaki M; Yoshida Y; Tokuhashi Y; Suzuki-Karasaki Y
Int J Oncol; 2017 Jul; 51(1):193-203. PubMed ID: 28560396
[TBL] [Abstract][Full Text] [Related]
24. Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins.
Mirandola P; Sponzilli I; Gobbi G; Marmiroli S; Rinaldi L; Binazzi R; Piccari GG; Ramazzotti G; Gaboardi GC; Cocco L; Vitale M
Int J Oncol; 2006 Jan; 28(1):127-33. PubMed ID: 16327988
[TBL] [Abstract][Full Text] [Related]
25. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
[TBL] [Abstract][Full Text] [Related]
26. Ether à go-go 1 silencing in combination with TRAIL overexpression has synergistic antitumor effects on osteosarcoma.
Wu J; Zeng T; Wu X; Gao Q; Zhai W; Ding Z
Cancer Biother Radiopharm; 2013 Feb; 28(1):65-70. PubMed ID: 23145797
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation.
Sonnemann J; Trommer N; Becker S; Wittig S; Grauel D; Palani CD; Beck JF
Cancer Biol Ther; 2012 Apr; 13(6):417-24. PubMed ID: 22313685
[TBL] [Abstract][Full Text] [Related]
28. The role of SPARC/ON in human osteosarcoma.
Sergi CM
Adv Protein Chem Struct Biol; 2023; 133():181-192. PubMed ID: 36707201
[TBL] [Abstract][Full Text] [Related]
29. TRAIL responses are enhanced by nuclear export inhibition in osteosarcoma.
Phillips KL; Wright N; McDermott E; Cross NA
Biochem Biophys Res Commun; 2019 Sep; 517(2):383-389. PubMed ID: 31362889
[TBL] [Abstract][Full Text] [Related]
30. CCAR2 promotes a malignant phenotype of osteosarcoma through Wnt/β-catenin-dependent transcriptional activation of SPARC.
Chen L; Zhou SJ; Xu Y; Liao QM; Zou YS; Pei H
Biochem Biophys Res Commun; 2021 Nov; 580():67-73. PubMed ID: 34624572
[TBL] [Abstract][Full Text] [Related]
31. LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma.
Takeda S; Iwai A; Nakashima M; Fujikura D; Chiba S; Li HM; Uehara J; Kawaguchi S; Kaya M; Nagoya S; Wada T; Yuan J; Rayter S; Ashworth A; Reed JC; Yamashita T; Uede T; Miyazaki T
Anticancer Res; 2007; 27(2):761-8. PubMed ID: 17465200
[TBL] [Abstract][Full Text] [Related]
32. Bufalin Induces Apoptosis of Human Osteosarcoma U-2 OS Cells through Endoplasmic Reticulum Stress, Caspase- and Mitochondria-Dependent Signaling Pathways.
Lee CH; Shih YL; Lee MH; Au MK; Chen YL; Lu HF; Chung JG
Molecules; 2017 Mar; 22(3):. PubMed ID: 28287444
[TBL] [Abstract][Full Text] [Related]
33. Secreted protein acidic and rich in cysteine antagonizes bufalin-induced apoptosis in gastric cancer cells.
Li A; Qu X; Li Z; Qu J; Song N; Ma Y; Liu Y
Mol Med Rep; 2015 Aug; 12(2):2926-32. PubMed ID: 25936899
[TBL] [Abstract][Full Text] [Related]
34. Epoxomicin Sensitizes Resistant Osteosarcoma Cells to TRAIL Induced Apoptosis.
Hanikoglu F; Cort A; Ozben H; Hanikoglu A; Ozben T
Anticancer Agents Med Chem; 2015; 15(4):527-33. PubMed ID: 25666501
[TBL] [Abstract][Full Text] [Related]
35. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
36. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
37. The interaction between SPARC and GRP78 interferes with ER stress signaling and potentiates apoptosis via PERK/eIF2α and IRE1α/XBP-1 in colorectal cancer.
Chern YJ; Wong JCT; Cheng GSW; Yu A; Yin Y; Schaeffer DF; Kennecke HF; Morin G; Tai IT
Cell Death Dis; 2019 Jun; 10(7):504. PubMed ID: 31243264
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial division inhibitor-1 induces mitochondrial hyperfusion and sensitizes human cancer cells to TRAIL-induced apoptosis.
Akita M; Suzuki-Karasaki M; Fujiwara K; Nakagawa C; Soma M; Yoshida Y; Ochiai T; Tokuhashi Y; Suzuki-Karasaki Y
Int J Oncol; 2014 Nov; 45(5):1901-12. PubMed ID: 25174275
[TBL] [Abstract][Full Text] [Related]
39. Gadolinium chloride elicits apoptosis in human osteosarcoma U-2 OS cells through extrinsic signaling, intrinsic pathway and endoplasmic reticulum stress.
Tsai YF; Huang CW; Chiang JH; Tsai FJ; Hsu YM; Lu CC; Hsiao CY; Yang JS
Oncol Rep; 2016 Dec; 36(6):3421-3426. PubMed ID: 27748868
[TBL] [Abstract][Full Text] [Related]
40. The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death.
Nguyen DM; Yeow WS; Ziauddin MF; Baras A; Tsai W; Reddy RM; Chua A; Cole GW; Schrump DS
Cancer J; 2006; 12(4):257-73. PubMed ID: 16925970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
